Calidi Biotherapeutics In... (CLDI)
AMEX: CLDI
· Real-Time Price · USD
1.60
-0.06 (-3.61%)
At close: Oct 16, 2025, 3:59 PM
1.59
-0.62%
After-hours: Oct 16, 2025, 07:49 PM EDT
-3.61% (1D)
| Bid | 1.6 |
| Market Cap | 4.6M |
| Revenue (ttm) | 1.5M |
| Net Income (ttm) | -19.85M |
| EPS (ttm) | -0.2 |
| PE Ratio (ttm) | -8 |
| Forward PE | -0.3 |
| Analyst | n/a |
| Dividends | n/a |
| Ask | 1.71 |
| Volume | 74,693 |
| Avg. Volume (20D) | 516,491 |
| Open | 1.69 |
| Previous Close | 1.66 |
| Day's Range | 1.60 - 1.70 |
| 52-Week Range | 1.41 - 46.68 |
| Beta | 1.07 |
| Ex-Dividend Date | n/a |
About CLDI
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol CLDI
Website n/a
1 month ago
-42.67%
Calidi Biotherapeutics shares are trading lower af...
Unlock content with
Pro Subscription
2 months ago
+14.85%
Calidi Biotherapeutics shares are trading higher after the company announced it has received FDA Fast Track Designation for CLD-201.
2 months ago · fool.com
Calidi Loss Down 23 Percent in Fiscal Q2Calidi Loss Down 23 Percent in Fiscal Q2